Atlas Trials

Anesthesia, General

168 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Anesthesia, General

RecordFirmDate
A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part A: Japanese Participants (P05956) (NCT00591409)Merck Sharp & Dohme LLC2006-01-03
A Bridging Trial Comparing Sugammadex (Org 25969) at 1-2 Post-Tetanic Count (PTC) in Japanese Participants. Part A (P05957) (NCT00591786)Merck Sharp & Dohme LLC2005-12-05
Comparison of Sugammadex (MK-8616/Org 25969) With Neostigmine Administered at 1-2 Post-tetanic Counts (PTCs) After Administration of Rocuronium or Vecuronium (19.4.302/P05945/MK-8616-025) (NCT00473694)Merck Sharp & Dohme LLC2005-11-28
Comparison of Sugammadex (Org 25969) With Neostigmine as Reversal Agents for Rocuronium or Vecuronium at Reappearance of T2 (P05960) (NCT00451217)Merck Sharp & Dohme LLC2005-11-17
Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931) (NCT00451100)Merck Sharp & Dohme LLC2005-11-10
Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023) (NCT00298831)Merck Sharp & Dohme LLC2005-10-27
A Bridging Trial Comparing Sugammadex (Org 25969) at 1-2 Post-Tetanic Count (PTC) in Caucasian Participants. Part B (P05974) (NCT00552929)Merck Sharp & Dohme LLC2005-10-04
A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part B: Caucasian Participants (P05971) (NCT00552617)Merck Sharp & Dohme LLC2005-09-20
Homocysteine After Nitrous Oxide Anesthesia (NCT00482456)Medical University of Vienna2005-01-01
Recovery From General Anesthesia (NCT00165971)Emory University2003-12-01
Use of Sugammadex Administered at 5 Minutes After Administration of 1.2 mg/kg Esmeron® (19.4.205)(P05942) (NCT00379613)Merck Sharp & Dohme LLC2003-11-07
← Previous

Track Anesthesia, General automatically

Every clearance here is in the API, with alerts when new ones post.